PeptiDream Inc. (PPTDF)
11.00
-0.75
(-6.38%)
USD |
OTCM |
Jan 09, 16:00
PeptiDream Research and Development Expense (Quarterly): 7.889M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 1.095B |
| Nxera Pharma Co., Ltd. | 25.27M |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 3.167M |
| AnGes, Inc. | 5.555M |